Tech Company Inital Public Offerings
Pyxis Oncology IPO
Headquartered in Cambridge, Pyxis Oncology is now a public company.
Transaction Overview
Company Name
Announced On
10/8/2021
Transaction Type
IPO
Amount
$168,000,000
Proceeds Purpose
Pyxis currently intends to use the net proceeds from the offering, together with its existing funding to advance its preclinical candidates (PYX-201, PYX-202, and PYX-203) through investigational new drug (IND) enabling studies. Depending on these results, the company would then move forward with FDA review of an IND submission and initiate Phase 1 clinical trials. The funds also would be used for business development activities, including in-licensed programs, the identification and advancement of additional programs and development candidates, and to acquire, or invest in additional businesses, technologies, products or assets, according to the company.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
35 Cambridgepark Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Steinberg
Chief Executive Officer
Lara Sullivan
Chief Financial Officer
Robert Crane
Chief Operating Officer
Ritu Shah
Chief Scientific Officer
Ronald Herbst
Chief Technical Officer
Steve Monks
VP - Bus. Development
James Mutamba
Browse more venture capital transactions:
Prev: 10/8/2021: BrightHire venture capital transaction
Next: 10/8/2021: RoboTire venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs